Evidence map›Paper›PMID 40356774›Full record

ArticleFrontiers in physiology2025

Adam J Rossano, Lili Zhang, Jacob B Anderson, Heather L Holmes, Asim K Mandal, James W Decker, David B Mount, Michael F Romero

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adam J RossanoPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
Lili ZhangPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
Jacob B AndersonPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
Heather L HolmesPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
Asim K MandalRenal Division, Brigham and Womens Hospital and Harvard Medical School, Boston, MA, United States.
James W DeckerPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.
David B MountRenal Division, Brigham and Womens Hospital and Harvard Medical School, Boston, MA, United States.
Michael F RomeroPhysiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Funding

The Pathobiology of NephrolithiasisP01DK070756 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI CURHAN, GARY C. · 2007 to 2011
$8.4M
TRAINING IN TRANSLATIONAL RESEARCH: BENCH TO BEDSIDER25GM055252 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 1996 to 2022
$8.3M
VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONSU54DK100227 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2013 to 2017
$6.3M
Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
Post-baccalaureate Training in Biomedical ResearchR25GM075148 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 2006 to 2024
$6.1M
KIDNEY DISEASES RESEARCH TRAINING PROGRAMT32DK007013 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 1986 to 2023
$3.7M
Mayo Clinic Summer Undergraduate Research in Nephrology & UrologyR25DK101405 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL F. ROMERO · 2014 to 2026
$1.6M
NIA NIH HHS P50 AG044170NIDDK NIH HHS P01 DK070756NIDDK NIH HHS R25 DK101405NIDDK NIH HHS T32 DK007013NIDDK NIH HHS U54 DK100227NIGMS NIH HHS R25 GM055252NIGMS NIH HHS R25 GM075148
6 · The paper itself

Abstract

Introduction: Nephrolithiasis is a painful and costly healthcare complication. The most common kidney stones are composed of calcium oxalate and thus renal handling of oxalate is an important facet of understanding the pathogenesis of nephrolithiasis. Recently, the Methods: The objective of this work was to identify and characterize the Results: A putative basolateral oxalate transporter CG5002 ("Neat") was identified through sequence homology and displayed robust Cl Discussion: These data indicate Neat is a significant

Indexed as

bicarbonate transportDrosophila Slc26genetically encoded pH-sensorintracellular pHMalpighian tubuleoxalate transportrenal epithelia

Identifiers

PMID40356774
PMCPMC12066474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.